InvestorsHub Logo
Followers 30
Posts 4143
Boards Moderated 0
Alias Born 07/25/2007

Re: DragonBits post# 11827

Thursday, 06/19/2008 3:05:09 PM

Thursday, June 19, 2008 3:05:09 PM

Post# of 19309
<The EMEA barely approved ATryn, and then only after Genzyme intervened. I don't know if there have been any sales of ATryn, has there? Because at least if there has been sales that is some form of data that will reassure the FDA. >

John,

Why do you need to lie? The EMEA was going to exclude some patients from the data after the study had been completed even after the EMEA had already said those patients would be included. GTCB appealed to have all the patients included as the EMEA originally agreed. The experts on the CHMP review board agreed with GTCB so all the patients were included. You are purposely mispresenting the facts by suggesting it was a legal manuever that required the intervention of Genzyme and it is sickening to me, though not as much as watching the GTCB price come down.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.